EUVIMEDEUVIMED entdecken
Open Access

Eosinophil Peroxidase: A Biomarker for Eosinophilic Chronic Rhinosinusitis Agnostic of Polyp Status

Beau M Idler iD, Koji Iijima, Sergei I Ochkur, Elizabeth A Jacobsen, Matthew A Rank, Hirohito Kita, Devyani Lal iD

The Laryngoscope · 2024

DOI: 10.1002/lary.30787 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Laryngoscope, 2024. Verfasst von Beau M Idler und 6 weiteren Autor:innen. Beteiligte Einrichtung: Mayo Clinic Alix School of Medicine, Mayo Clinic Arizona, Scottsdale, Arizona, USA. Hauptthemen laut MEDLINE: Eosinophilia, Nasal Polyps, Rhinitis, Rhinosinusitis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Flinn Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate eosinophil peroxidase (EPX) as a biomarker for tissue levels of eosinophilia, cytokines, and chemokines within chronic rhinosinusitis (CRS).

Methods

Twenty‐eight subjects undergoing sinonasal surgery were prospectively enrolled. Ethmoid tissue was analyzed with an in‐house EPX immunoassay and a 48‐plex cytokine‐chemokine array. Clinical severity was assessed using SNOT‐22 and Lund‐Mackay scores. Subjects were grouped as follows: controls, polyp status (CRS with [CRSwNP] and without nasal polyps [CRSsNP]), tissue eosinophilia (eosinophilic CRS [eCRS], non‐eosinophilic CRS [neCRS]), or combinations thereof (eCRSwNP, eCRSsNP, neCRSsNP). eCRS was defined as >10 eosinophils per high power field (HPF). Subjects without CRS or asthma were enrolled as controls.

Results

EPX was elevated in CRSwNP compared to control ( p = 0.007), in eCRS compared to neCRS ( p = 0.002), and in eCRSwNP along with eCRSsNP compared to neCRSsNP ( p = 0.023, p = 0.015, respectively). eCRS displayed elevated IL‐5 compared to neCRS ( p = 0.005). No significant differences in EPX or IL‐5 were observed between eCRSwNP and eCRSsNP. IL‐5 was elevated in eCRSwNP ( p = 0.019) compared neCRSsNP. Area under the receiver operator characteristic curve was 0.938 (95% CI, 0.835–1.00) for EPX and tissue eosinophilia, with an optimal cut‐point of 470 ng/mL being 100% specific and 81.25% sensitive for tissue eosinophilia. Linear regression revealed a strong correlation between EPX and IL‐5 (R 2 = 0.64, p < 0.001). Comparing EPX and IL‐5, only EPX displayed significant correlation with SNOT‐22 ( p = 0.04) and Lund‐Mackay score ( p = 0.004).

Conclusion

EPX is associated with tissue eosinophilia in CRS patients regardless of polyp status. EPX correlates with IL‐5 and could be potentially considered a biomarker for anti‐IL‐5 therapies. Level of Evidence 3 Laryngoscope , 134:69–78, 2024

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EosinophiliaNasal PolypsRhinitisRhinosinusitisSinusitisHumansBiomarkersChronic DiseaseCytokinesEosinophil PeroxidaseEosinophilsInterleukin-5

Stichwörter der Autor:innen

IL-5biomarkerchronic rhinosinusitiseosinophil peroxidaseeosinophiliainterleukin 5nasal polypssinusitis

Substanzen

BiomarkersCytokinesEosinophil PeroxidaseInterleukin-5EPX protein, human

Autor:innen und Institutionen

  • Mayo Clinic Alix School of Medicine, Mayo Clinic Arizona, Scottsdale, Arizona, USA.
  • Division of Allergy, Asthma, and Clinical Immunology, Mayo Clinic Arizona, Scottsdale, Arizona, USA.
  • Department of Otorhinolaryngology-Head and Neck Surgery, Mayo Clinic Arizona, Phoenix, Arizona, USA.

ORCID-Profile: Beau M Idler, Devyani Lal

Förderung

  • NIAID NIH HHS
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases
  • Flinn Foundation

Zitieren

APA

Idler, B. M., Iijima, K., Ochkur, S. I., Jacobsen, E. A., Rank, M. A., Kita, H., & Lal, D. (2024). Eosinophil Peroxidase: A Biomarker for Eosinophilic Chronic Rhinosinusitis Agnostic of Polyp Status. The Laryngoscope. https://doi.org/10.1002/lary.30787

Vancouver

Idler BM, Iijima K, Ochkur SI, Jacobsen EA, Rank MA, Kita H, et al. Eosinophil Peroxidase: A Biomarker for Eosinophilic Chronic Rhinosinusitis Agnostic of Polyp Status. The Laryngoscope. 2024. doi:10.1002/lary.30787

BibTeX
@article{Idler2024,
  author = {Idler, Beau M and Iijima, Koji and Ochkur, Sergei I and Jacobsen, Elizabeth A and Rank, Matthew A and Kita, Hirohito and Lal, Devyani},
  title = {Eosinophil Peroxidase: A Biomarker for Eosinophilic Chronic Rhinosinusitis Agnostic of Polyp Status},
  journal = {The Laryngoscope},
  year = {2024},
  doi = {10.1002/lary.30787}
}
Kostenlos starten →